Universal neonatal hearing screening

Last updated
Universal neonatal hearing screening
NeonatalHearingScreening.jpg
A newborn infant undergoes a hearing screening.
Purposeearly intervention/identification of deaf or hard-of-hearing infants

Universal neonatal hearing screening (UNHS), which is part of early hearing detection and intervention (EHDI) programmes, refer to those services aimed at screening hearing of all newborns, regardless of the presence of a risk factor for hearing loss. UNHS is the first step in the EHDI program which indicates whether a newborn requires further audiological assessment to determine the presence or absence of permanent hearing loss. Newborn hearing screening uses objective testing methods (usually otoacoustic emission (OAE) testing or automated auditory brainstem response (ABR) testing) to screen the hearing of all newborns in a particular target region, regardless of the presence or absence of risk factors. Even among developed countries, until the 1990s, it could take years for hearing-impaired child to be diagnosed and to benefit from a health intervention and amplification. This delay still can happen in developing countries. [1] If children are not exposed to sounds and language during their first years of life because of a hearing loss, they will have difficulty in developing spoken or signed language; cognitive development and social skills could also be affected. [2] This screening separates children into two groups—those with a high index of suspicion (more likely to have permanent congenital hearing loss) and those with a low index of suspicion (less likely to have permanent congenital hearing loss). Those in the first group are referred for diagnostic testing. [3]

Contents

Newborn hearing screening has been implemented in many regions worldwide since the early 2000s as it aims to reduce the age of detection for hearing loss—meaning that diagnosed children can receive early intervention, which is more effective because the brain's ability to learn language (spoken, cued, or signed) reduces as the child ages. [4] Children born with permanent congenital hearing loss have historically performed worse educationally, had poorer language acquisition, social functioning and vocational choices than their hearing peers. [5] [6] [7] [8]

Overview

In order to be most effective in minimizing developmental delays and promoting communication, education and social development, timely and appropriate interventions need to follow the early identification of hearing loss. Interventions for children with permanent congenital hearing loss ranges from devices that amplify sound to devices that replace the function of a damaged inner ear to communication modalities including spoken language, sign language, and cued speech. The choice of interventions depends on the degree and the cause of hearing loss, accessibility, affordability and family choice. For interventions to be effective, they should be appropriate, timely, family-centered and undertaken through a coordinated interdisciplinary approach, which includes access to specialists who have the professional qualifications and specialized knowledge and skills to support and promote optimal development outcomes. [9] Key elements for ensuring the best outcomes for children with hearing loss may include: [10]

EHDI programmes exist in many countries, including the United States, [11] United Kingdom, [12] Australia, [13] [14] New Zealand, [15] and the majority of countries making up the European Union. [16] In order to maximize language and communication competence, literacy development, and psychosocial well-being, the U.S. Joint Committee on Infant Hearing [17] endorses the goals that 1) all newborns should undergo hearing screening using physiologic measures prior to hospital discharge, but no later than one month of age 2) all infants whose do not pass screening should have appropriate audiologic diagnosis no later than three months of age and 3) all infants identified as deaf or hard of hearing in one or both ears should be referred to early targeted and appropriate intervention services as soon as possible after diagnosis, but no later than six months of age. Newborn hearing screening employs objective assessment methods, either with automated (ABR) or (OAE), or both for initial and/or rescreening procedures. [18]

Rates of congenital hearing loss

Hearing loss in neonates is the most common congenital birth defect and sensory disorder, and can be caused by a variety of reasons. Research has placed the prevalence of significant permanent hearing loss in neonates at 1–2 per 1000 live births in the United States. [19] [20] With this screening, many forms of congenital hearing loss can be detected. Congenital hearing loss can be due to genetic causes, environmental exposures during pregnancy, or health complications shortly after birth. [21] Population-based studies in Europe and North America have identified a consistent prevalence of approximately 0.1% of children having a hearing loss of more than 40 decibels through review of health or education records, or both. Other international studies using different methods or criteria have reported higher estimates. [22] In the United States, studies have shown a wide range of estimates for the number of children with hearing loss depending upon the reported age range, type, degree, frequency, laterality and method of ascertainment (e.g. audiometric testing, parental report, record review). Audiometric data of adolescents aged 12 to 19 years obtained through the National Health and Nutrition Examination Survey (NHANES) identified 3% to 5% of adolescents with hearing loss of 25 decibels or more and 15% to 20% with hearing losses of greater than 15 decibels. [23]

Research studies

Studies have found that early diagnosis and intervention for children with hearing loss can help them develop better communication skills. Researchers have shown children with hearing loss meeting the current early identification and intervention guidelines were more likely to have enhanced vocabulary than children who did not meet EHDI 1-3-6 guidelines. [24] Funded research projects have focused on improving EHDI process issues including improving LFU/LTD rates through at Women, Infants, and Children (WIC) certification screening visits. [25] [26] and exploring technologies that can be incorporated in electrophysiological testing to facilitate hearing loss diagnosis in newborns, without the use of sedation. [27]

Investigators have reported on numerous topics including the screening and diagnostic evaluations of children with unilateral and mild bilateral hearing loss, [28] the impact of hearing loss and comorbidities, [29] and the long-term hearing loss risk of children born with cytomegalovirus. [30]

Screening methodology

Often a two-stage process occurs in the actual screening of the hearing. Children are screened with either otoacoustic emissions (OAE) or automated auditory brainstem response (AABR). Children passing the test receive no further assessment. Children who fail the initial screen are usually referred for a second screening assessment either with OAE's or AABR. Children failing this second assessment will usually be sent for diagnostic assessment of their hearing. There is some variation in procedure by region and country but most follow this basic principle. [1]

Screening personnel vary also, in some regions Audiologists are used, whereas technicians, nurses, or volunteers are used in other programs. In countries that have insufficient financial and human resources to implement hearing screening, community-based programs have used simple, behaviour-based questionnaires to identify infants with hearing loss but with limited success. [1]

Targeted hearing screening

Targeted neonatal hearing screening describes the process by which only a specific subset of a population are screened (for instance those infants in the neonatal intensive care unit or with risk factors for hearing loss). Although the U.S. Joint Committee on Infant Hearing (JCIH) endorsed the goal of universal detection of infants with hearing loss in 1994, it modified and maintained a role for specific high risk factors described in their previous (1973, 1982 and 1990) position statements. [31]

Successes

Universal newborn hearing screening programs aim to have high coverage rates (participation) and many aim to screen babies by one month of age, aim to complete the diagnostic process for referred babies by three months of age, and aim to begin intervention services by six months of age. [32]

U.S. jurisdictional programs (states and territories) screened less than 3% of all newborns for hearing loss in the U.S. at the beginning of the 1990s. [33] Data from states and territories for the early years of EHDI (1999–2004) were collected using surveys conducted by the Directors of Speech and Hearing Programs in State Health and Welfare Agencies [34] and shared with the CDC EHDI Program. [35] [36] Beginning in 2005, CDC obtained data through an Office of Management and Budget approved survey sent to EHDI programme directors. In 1999, 22 jurisdictions estimated that less than half of all infants (46.5%) were screened for hearing loss, steadily increasing to 80.1% in 2005 85.4% in 2007, and 98.0% by 2009. [37] The number of deaf and hard of hearing babies identified early in life in the U.S. has steadily increased from 855 in the year 2000, 2,634 in 2005 and most recently reported 6,337 in calendar year 2016. [38]

Challenges

In addition to meeting the "1-3-6" targets, one of the key challenges for newborn hearing screening programmes is to reduce 'loss to follow-up' (where a child does not return for the next stage of the process). The Joint Committee on Infant Hearing (US) has reported that this is a significant problem in state screening programmes in the United States and other jurisdictions. Measuring loss to follow-up is an important step in understanding and reducing it. [39]

Now that over 95% of U.S. infants are having their hearing screened, remaining challenges include ensuring timely diagnostic evaluation for those who do not pass the screening and enrollment in early intervention for those with diagnosed hearing loss. In 2005, >60% of infants who had not passed the final or most recent screening were lost-to-follow-up/lost to documentation (LFU/LTD). [40] Some of those infants may have received audiologic evaluations, but the results not reported to the EHDI programme (i.e., undocumented evaluation). By 2007, LFU/LTD among infants not passing the final or most recent screening had decreased to approximately 46% and to 35% in 2011. The LFU/LTD percent for diagnosis in 2016 was 25.4% (n = 16,522). The 2016 LFU/LTD percent for enrollment in early intervention was 19.6% (n = 1,239). [37]

Challenges to newborn hearing screening have existed for over three decades. [41] Newborn screening alone can miss postnatal, progressive or acquired hearing loss, there is poor identification of perinatal infections, and concerns over regulatory barriers and privacy continue to this day. [42] Many infants are lost to follow-up and many families face the challenge of navigating coordinated quality care through complex health to education systems involving multiple agencies. [43] [44] [45]

History

In 1956, Erik Wedenberg published one of the earliest articles describing examiner use of tuning forks, percussion sounds, pitch pipes, and cowbells to screen the hearing newborn infants. The author noted, "until recently it has not been considered possible to carry out reliable auditory tests until the child has attained the age of 6–7 years." [46]

In 1963, Marion Downs, affectionately referred to as the "mother of pediatric audiology", pioneered the first hospital based infant hearing screening programme in Denver, Colorado, using Behavioral Observation Audiometry (BOA). Several independent observers recorded eye-blink and/or startle responses after presentation of narrow-band (90 dB) and white noise (93 dB) stimulation. In her 1964 publication, the observers identified suspected hearing losses, although disagreements were significant for 26% of the infants. [41] In 1969, Marion led efforts for the formation of the Joint Committee on Infant Hearing (JCIH) to provide multi-disciplinary leadership and guidance in all areas of newborn and infant hearing issues. [17]

In their 1971 Position Statement, the JCIH determined the results of screening programs were inconsistent and misleading and, although recognizing the urgent need for early detection, recommended discontinuing routine behavioral hearing screening of newborn infants. In 1973 the Committee recommended that only infants with certain high risk factors have their hearing evaluated (five factors: family history; congenital perinatal infections; ear, nose or throat defects; low birthweight <1500 g; hyperbilirubinemia). [47]

In 1982, two additional risk factors were added (bacterial meningitis and birth asphyxia including low Apgar scores) and included the recommendation for BOA or physiologic screening of high-risk infants. At that time, the Committee did not recommend any specific device, although many programme were successfully utilizing automated ABR for newborn screening. Despite efforts and endorsements, the growth of high-risk screening in the United States was very slow. [48] In 1984, high-risk hearing registries only included an estimated 15 percent of the nation's newborn population and likely, that less than half of those infants had their hearing assessed. Other weaknesses identified that a restricted risk register will excludes approximately 50 percent of infants with hearing impairment. [49]

In 1989 Surgeon General C. Everett Koop, perhaps most remembered for his work related to abortion, tobacco, and AIDS, called for increased efforts to identify congenital hearing loss within the first year of life. In his words, "It's a tall order, yes, but if we all work together, I believe we can fill it." [50]

In 1990, the JCIH added three more risk factors (ototoxic medication, prolonged mechanical ventilation, syndromic stigmata) for a total of ten. Congressman James T. Walsh (R-NY) sponsored and introduced the first attempt at federal legislation with the Hearing Loss Testing Act of 1991 [51] requiring the hearing testing of every child born in the United States at the time of birth and establishing uniform standards for such testing. Although the Committee on Energy and Commerce referred this legislation to subcommittee, Congressman Walsh continued to promote legislation throughout that decade as the co-founder and co-chair of the Congressional Hearing Health Caucus. In 1993, the National Institutes of Health Consensus statement initiated the concept of "1-3-6" as the monthly milestones for screening, diagnosis and intervention. Between 1993 and 1996, the National Center for Hearing Assessment and Management at Utah State University conducted the Rhode Island Hearing Assessment Project (RIHAP), which demonstrated the feasibility of using transient OAEs for universal screening. [52] [53] In 1994, both the JCIH and the DSHPSHWA endorsed universal newborn hearing screening. In 1996, the US Preventive Services Task Force concluded that the evidence was insufficient to assess the balance of benefits and harms and assigned an "I Statement" grade for newborn hearing screening. [54]

All US states participate in Early Hearing Detection and Intervention (EHDI) programmes. [55] The birth of EHDI may be attributed to passage of the Children's Health Act of 2000 which included language from Walsh's proposed legislation and authorized the Secretary of the Department of Health and Human Services, acting through the Centers for Disease Control and Prevention and the Health Resources and Services Administration, to establish "statewide newborn and infant hearing screening evaluation and intervention programs and systems." Congress provided HRSA with the authority to support statewide services and the CDC with the authority to provide technical assistance for data management and applied research. In addition, the National Institute on Deafness and Other Communication Disorders at NIH provided the authority to continue a programme of research and development on the efficacy of new screening techniques and technology. [56]

The year 2000 Position Statement of the JCIH provided the Principles and Guidelines for Early Hearing Detection and Intervention Programs. In 2006, the HHS Secretary's Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) included newborn hearing as one of the conditions to be included in their Recommended Uniform Screening Panel (RUSP). [33] With growing research evidence, in 2007 United States Preventive Services Task Force (USPSTF) recommended screening of hearing loss in all newborn infants with an assigned B grade. By 2010, 43 states enacted legislative statutes or written regulatory language related to universal newborn hearing screening. [57]

The electronic age of EHDI may have begun during the next decade. The Quality, Research, and Public Health (QRPH) Planning and Technical Committees of Integrating the Healthcare Enterprise published a series of EHDI technical documents. [58] These profiles promote the automated collection and communication exchange of EHDI data between clinical and public health information systems (results, demographics, care plans, quality measures). The U.S. National Library of Medicine maintains the Newborn Screening Coding and Terminology Guide [59] to promote and facilitate the use of electronic health data standards in recording and transmitting newborn screening test results. This includes EHDI standard vocabulary codes and terminologies, including Logical Observation Identifiers Names and Codes (LOINC), Systematized Nomenclature of Medicine — Clinical Terms (SNOMED CT). The National Quality Forum the Centers for Medicare & Medicaid Services, and the Joint Commission for hospital accreditation have endorsed and/or supported adoption of EHDI electronic quality measures. [60] EHDI-PALS (Pediatric Audiology Links to Services) provides web-based link to information, resources, and services for children with hearing loss. [61] In 2018, Health Level 7 (HL7) approved the Early Hearing Detection and Intervention (EHDI) Implementation Guide as a Normative Standard. [62]

Situation worldwide

In 2014 to 2019 the International Newborn and Infant Hearing Screening (NIHS) Group asked via questionnaire for the status of the hearing screening in 196 states worldwide; data from 158 states were obtained: in 64 states there is no or less screening (38% of the world's population); in 41 states (38% of the world's population) >85% of the babies are screened. The mean living standard in these states was 10 times higher than in countries without screening. It could show how useful a hearing screening can be: average age at diagnosis of hearing disorders was 4.6 months for screened children and 34.9 months for non-screened children. [63]

Related Research Articles

<span class="mw-page-title-main">Hearing loss</span> Partial or total inability to hear

Hearing loss is a partial or total inability to hear. Hearing loss may be present at birth or acquired at any time afterwards. Hearing loss may occur in one or both ears. In children, hearing problems can affect the ability to acquire spoken language, and in adults it can create difficulties with social interaction and at work. Hearing loss can be temporary or permanent. Hearing loss related to age usually affects both ears and is due to cochlear hair cell loss. In some people, particularly older people, hearing loss can result in loneliness.

<span class="mw-page-title-main">Congenital rubella syndrome</span> Medical condition

Congenital rubella syndrome (CRS) occurs when an unborn baby is infected with the rubella virus via maternal-fetal transmission and develops birth defects. The most common congenital defects affect the ophthalmologic, cardiac, auditory, and neurologic systems.

<span class="mw-page-title-main">Newborn screening</span> Practice of testing infants for diseases

Newborn screening (NBS) is a public health program of screening in infants shortly after birth for conditions that are treatable, but not clinically evident in the newborn period. The goal is to identify infants at risk for these conditions early enough to confirm the diagnosis and provide intervention that will alter the clinical course of the disease and prevent or ameliorate the clinical manifestations. NBS started with the discovery that the amino acid disorder phenylketonuria (PKU) could be treated by dietary adjustment, and that early intervention was required for the best outcome. Infants with PKU appear normal at birth, but are unable to metabolize the essential amino acid phenylalanine, resulting in irreversible intellectual disability. In the 1960s, Robert Guthrie developed a simple method using a bacterial inhibition assay that could detect high levels of phenylalanine in blood shortly after a baby was born. Guthrie also pioneered the collection of blood on filter paper which could be easily transported, recognizing the need for a simple system if the screening was going to be done on a large scale. Newborn screening around the world is still done using similar filter paper. NBS was first introduced as a public health program in the United States in the early 1960s, and has expanded to countries around the world.

<span class="mw-page-title-main">Audiology</span> Branch of science that studies hearing, balance, and related disorders

Audiology is a branch of science that studies hearing, balance, and related disorders. Audiologists treat those with hearing loss and proactively prevent related damage. By employing various testing strategies, audiologists aim to determine whether someone has normal sensitivity to sounds. If hearing loss is identified, audiologists determine which portions of hearing are affected, to what degree, and where the lesion causing the hearing loss is found. If an audiologist determines that a hearing loss or vestibular abnormality is present, they will provide recommendations for interventions or rehabilitation.

Auditory neuropathy (AN) is a hearing disorder in which the outer hair cells of the cochlea are present and functional, but sound information is not transmitted sufficiently by the auditory nerve to the brain. Hearing loss with AN can range from normal hearing sensitivity to profound hearing loss.

<span class="mw-page-title-main">Neonatology</span> Medical care of newborns, especially the ill or premature

Neonatology is a subspecialty of pediatrics that consists of the medical care of newborn infants, especially the ill or premature newborn. It is a hospital-based specialty and is usually practised in neonatal intensive care units (NICUs). The principal patients of neonatologists are newborn infants who are ill or require special medical care due to prematurity, low birth weight, intrauterine growth restriction, congenital malformations, sepsis, pulmonary hypoplasia, or birth asphyxia.

<span class="mw-page-title-main">Group B streptococcal infection</span> Medical condition

Group B streptococcal infection, also known as Group B streptococcal disease or just Group B strep infection, is the infectious disease caused by the bacterium Streptococcus agalactiae, which is also known as group B streptococcus or GBS. Infection with GBS can cause serious illness and sometimes death, especially in newborns, the elderly, and people with compromised immune systems. The most severe form of group B streptococcal disease is neonatal meningitis in infants, which is frequently lethal and can cause permanent neuro-cognitive impairment.

The red reflex refers to the reddish-orange reflection of light from the back of the eye, or fundus, observed when using an ophthalmoscope or retinoscope. The reflex relies on the transparency of optical media and reflects off the fundus back through media into the aperture of the ophthalmoscope. The red reflex is considered abnormal if there is any asymmetry between the eyes, dark spots, or white reflex (Leukocoria).

<span class="mw-page-title-main">Hip dysplasia</span> Joint abnormality

Hip dysplasia is an abnormality of the hip joint where the socket portion does not fully cover the ball portion, resulting in an increased risk for joint dislocation. Hip dysplasia may occur at birth or develop in early life. Regardless, it does not typically produce symptoms in babies less than a year old. Occasionally one leg may be shorter than the other. The left hip is more often affected than the right. Complications without treatment can include arthritis, limping, and low back pain. Females are affected more often than males. Risk factors for hip dysplasia include female sex, family history, certain swaddling practices, and breech presentation whether an infant is delivered vaginally or by cesarean section. If one identical twin is affected, there is a 40% risk the other will also be affected. Screening all babies for the condition by physical examination is recommended. Ultrasonography may also be useful.

Marion Downs was an American audiologist and Professor Emerita at the University of Colorado Health Sciences Center, Denver, who pioneered universal newborn hearing screening in the early 1960s, then spent more than 30 years trying to convince her peers to adopt the testing in hospitals and to place hearing aids on infants who showed hearing loss. She worked to alert the medical world to the developmental problems associated with childhood deafness. As a result of her efforts, 95 percent of all newborns in America today are screened for hearing loss. She devoted her professional life to the promotion of early identification of hearing loss in newborns, infants, and young children and to helping deaf and hard of hearing individuals lead fulfilling lives.

<span class="mw-page-title-main">Congenital cytomegalovirus infection</span> Medical condition

Congenital cytomegalovirus (cCMV) is cytomegalovirus (CMV) infection in a newborn baby. Most have no symptoms. Some affected babies are small. Other signs and symptoms include a rash, jaundice, hepatomegaly, retinitis, and seizures. It may lead to loss of hearing or vision, developmental disability, or a small head.

Neonatal sepsis is a type of neonatal infection and specifically refers to the presence in a newborn baby of a bacterial blood stream infection (BSI) in the setting of fever. Older textbooks may refer to neonatal sepsis as "sepsis neonatorum". Criteria with regards to hemodynamic compromise or respiratory failure are not useful clinically because these symptoms often do not arise in neonates until death is imminent and unpreventable. Neonatal sepsis is divided into two categories: early-onset sepsis (EOS) and late-onset sepsis (LOS). EOS refers to sepsis presenting in the first 7 days of life, with LOS referring to presentation of sepsis after 7 days. Neonatal sepsis is the single most common cause of neonatal death in hospital as well as community in developing country.

Neonatal withdrawal or neonatal abstinence syndrome (NAS) or neonatal opioid withdrawal syndrome (NOWS) is a withdrawal syndrome of infants after birth caused by in utero exposure to drugs of dependence, most commonly opioids. Common signs and symptoms include tremors, irritability, vomiting, diarrhea, and fever. NAS is primarily diagnosed with a detailed medication history and scoring systems. First-line treatment should begin with non-medication interventions to support neonate growth, though medication interventions may be used in certain situations.

The National Center for Hearing Assessment and Management (NCHAM) was founded in 1990 at Utah State University in Logan, Utah.

An audiologist, according to the American Academy of Audiology, "is a person who, by virtue of academic degree, clinical training, and license to practice and/or professional credential, is uniquely qualified to provide a comprehensive array of professional services related to the prevention of hearing loss and the audiologic identification, assessment, diagnosis, and treatment of persons with impairment of auditory and vestibular function, and to the prevention of impairments associated with them."

Despite having the largest economy in South America or Central America, Brazil is still considered a developing country due to its low gross domestic product, or GDP, per capita, low living standards, high infant mortality rate and other factors. "With regard to hearing health, the Brazilian government established the national policy for giving attention to hearing health in 2004, in which the Ministry of Health, considering the social magnitude of hearing impairment in the Brazilian population and its consequences, presented the proposal to structure a network of services set up by regions and in hierarchy that aims to be implemented in all federative units of Brazil, with integrated actions to promote ear health, hearing impairment prevention, treatment and rehabilitation organized and managed by the National Health System, Sistema Único de Saúde (SUS), in Portuguese," writes Bevilacqua et al. (2010)

<span class="mw-page-title-main">Annamarie Saarinen</span>

Annamarie Saarinen is an American health advocate, economist and co-founder of the Newborn Foundation, a 501(c)(3) organization that aims to accelerate the pace of early detection and intervention for treatable newborn health conditions. Saarinen also co-founded Bloom Standard, a social impact innovation lab developing early diagnostic technologies for children in remote and resource poor settings.

<span class="mw-page-title-main">Melissa Wake</span> New Zealand paediatric academic

Melissa Anne Wake MBChB MD FRACP FAHMS is a New Zealand paediatrician and Scientific Director of the Generation Victoria initiative, aiming to create very large, parallel whole-of-state birth and parent cohorts in Victoria, Australia, for Open Science discovery and interventional research. She is Group Leader of the Murdoch Children's Research Institute’s Prevention Innovation Research Group and holds Professorial positions with the University of Melbourne and the University of Auckland.

Bolajoko Olubukunola Olusanya is a Nigerian paediatrician and social entrepreneur. She is a specialist in audiological medicine.

According to The Deaf Unit Cairo, there are approximately 1.2 million deaf and hard of hearing individuals in Egypt aged five and older. Deafness can be detected in certain cases at birth or throughout childhood in terms of communication delays and detecting language deprivation. The primary language used amongst the deaf population in Egypt is Egyptian Sign Language (ESL) and is widely used throughout the community in many environments such as schools, deaf organizations, etc. This article focuses on the many different aspects of Egyptian life and the impacts it has on the deaf community.

References

  1. 1 2 3 McPherson B (2012). "Newborn hearing screening in developing countries: needs & new directions". The Indian Journal of Medical Research. 135 (2): 152–3. PMC   3336843 . PMID   22446854.
  2. ↑ "NIH Fact Sheets: Newborn Hearing Screening". U.S. National Institutes of Health. Retrieved 2019-03-01.
  3. ↑ Wilson JMG; Jungner G (1968). "Principles and practice of screening for disease". World Health Organization. Retrieved 6 March 2019.
  4. ↑ Downs MP, Yoshinaga-Itano C (February 1999). "The efficacy of early identification and intervention for children with hearing impairment". Pediatric Clinics of North America. 46 (1): 79–87. doi:10.1016/S0031-3955(05)70082-1. PMID   10079791.
  5. ↑ Mayberry RI, Lock E, Kazmi H (May 2002). "Linguistic ability and early language exposure". Nature. 417 (6884): 38. doi: 10.1038/417038a . PMID   11986658. S2CID   4313378.
  6. ↑ Johnson JS, Newport EL (June 1991). "Critical period effects on universal properties of language: the status of subjacency in the acquisition of a second language". Cognition. 39 (3): 215–58. doi:10.1016/0010-0277(91)90054-8. PMID   1841034. S2CID   13278854.
  7. ↑ Yoshinaga-Itano C (2003). "From Screening to Early Identification and Intervention: Discovering Predictors to Successful Outcomes for Children With Significant Hearing Loss". Journal of Deaf Studies and Deaf Education. 8 (1): 11–30. doi: 10.1093/deafed/8.1.11 . PMID   15448044.
  8. ↑ Neville H, Bavelier D (2002). "Human brain plasticity: evidence from sensory deprivation and altered language experience". Plasticity in the Adult Brain: From Genes to Neurotherapy. Progress in Brain Research. Vol. 138. pp. 177–88. doi:10.1016/S0079-6123(02)38078-6. ISBN   9780444509819. PMID   12432770.
  9. ↑ Muse C, Harrison J, Yoshinaga-Itano C, Grimes A, Brookhouser PE, Epstein S, Buchman C, Mehl A, Vohr B, Moeller MP, Martin P (Apr 2013). "Supplement to the JCIH 2007 Position Statement: Principles and Guidelines for Early Intervention After Confirmation That a Child Is Deaf or Hard of Hearing". Pediatrics. 131 (4): e1324–e1349. doi: 10.1542/peds.2013-0008 . PMID   23530178. S2CID   1725667.
  10. ↑ Childhood hearing loss: strategies for prevention and care. World Health Organization. 2016. hdl:10665/204632. ISBN   9789241510325.
  11. ↑ "EHDI Programs". U.S. Centers for Disease Control and Prevention. 2017-11-14.
  12. ↑ "NHS Newborn Hearing Screening Programme Home Page". UK National Health Service.
  13. ↑ "National Framework for Neonatal Hearing Screening". Australian Government Department of Health and Aged Care. 2013. Retrieved 31 January 2023.
  14. ↑ "Australasian Newborn Hearing Screening Committee" . Retrieved 2023-01-30.
  15. ↑ "Universal Newborn Hearing Screening Programme". New Zealand National Screening Unit.
  16. ↑ Levêque, Alain; Tognola, Gabriella; Lagasse, Raphaël; Senterre, Christelle; Vos, Bénédicte (2016-06-01). "Organisation of newborn hearing screening programmes in the European Union: widely implemented, differently performed". European Journal of Public Health. 26 (3): 505–510. doi: 10.1093/eurpub/ckw020 . ISSN   1101-1262. PMID   27009037.
  17. 1 2 "Joint Committee on Infant Hearing" . Retrieved 2019-03-01.
  18. ↑ "Newborn Hearing Screening". American Speech-Language-Hearing Association (ASHA). Retrieved 6 March 2019.
  19. ↑ Thompson DC, McPhillips H, Davis RL, Lieu TL, Homer CJ, Helfand M (24 October 2001). "Universal newborn hearing screening: summary of evidence". JAMA. 286 (16): 2000–10. CiteSeerX   10.1.1.599.9440 . doi:10.1001/jama.286.16.2000. PMID   11667937.
  20. ↑ Wrightson AS (May 2007). "Universal newborn hearing screening". American Family Physician. 75 (9): 1349–52. PMID   17508530.
  21. ↑ "Hearing Loss at Birth (Congenital Hearing Loss)". American Speech-Language-Hearing Association. Retrieved 2019-03-04.
  22. ↑ "Published Literature on Prevalence of Hearing Loss in Children" (PDF). U.S. Centers for Disease Control and Prevention.
  23. ↑ Barrett TS, White KR (2017). "Trends in hearing loss among adolescents". Pediatrics. 140 (6): e20170619. doi: 10.1542/peds.2017-0619 . PMID   29117949. S2CID   21934188.
  24. ↑ Yoshinaga-Itano C, Sedey AL, Wiggin M, Chung W (2017). "Early Hearing Detection and Vocabulary of Children With Hearing Loss". Pediatrics. 140 (2): e20162964. doi:10.1542/peds.2016-2964. PMC   5595069 . PMID   28689189.
  25. ↑ Hunter LL, Meinzen-Derr J, Wiley S, Horvath CL, Kothari R, Wexelblatt S (July 2016). "Influence of the WIC Program on Loss to Follow-up for Newborn Hearing Screening". Pediatrics. 138 (1): e20154301. doi:10.1542/peds.2015-4301. PMC   4925076 . PMID   27307144.
  26. ↑ Seeliger EL, Martin RA, Gromoske AN, Harris, AB (2016). "WIC Participation as a Risk Factor for Loss to Follow-Up in the Wisconsin EHDI System". Journal of Early Hearing Detection and Intervention. 1 (1). doi:10.15142/T3KK5C.
  27. ↑ Cone B, Norrix L (2015). "Measuring the Advantage of Kalman-Weighted Averaging for Auditory Brainstem Response Hearing Evaluation in Infants". American Journal of Audiology. 24 (2): 153–168. doi:10.1044/2015_AJA-14-0021. PMID   25654653.
  28. ↑ Ross DS, Holstrum WJ, Gaffney M, Green D, Oyler RF, Gravel JS (Mar 2008). "Hearing Screening and Diagnostic Evaluation of Children With Unilateral and Mild Bilateral Hearing Loss". Trends Amplif. 12 (1): 27–34. doi:10.1177/1084713807306241. PMC   4111446 . PMID   18270176.
  29. ↑ Chapman DA, Stampfel CC, Bodurtha JN, Dodson KM, Pandya A, Lynch KB, Kirby RS (Dec 2011). "Impact of Co-Occurring Birth Defects on the Timing of Newborn Hearing Screening and Diagnosis". Am J Audiol. 20 (2): 132–139. doi:10.1044/1059-0889(2011/10-0049). PMC   4877695 . PMID   21940980.
  30. ↑ Lanzieri TM, Leung J, Caviness AC, Chung W, Flores M, Blum P, Bialek SR, Miller JA, Vinson SS, Turcich MR, Voigt RG (April 2017). "Long-term outcomes of children with symptomatic congenital cytomegalovirus disease". Journal of Perinatology. 37 (7): 875–880. doi:10.1038/jp.2017.41. PMC   5562509 . PMID   28383538.
  31. ↑ "Joint Committee on Infant Hearing 1994 position statement". Pediatrics. 95 (1): 152–6. Jan 1995. doi:10.1542/peds.95.1.152. PMID   7770297. S2CID   41306029.
  32. ↑ "Newborn and infant hearing screening: Current issues and guiding principles for action" (PDF). World Health Organization. Retrieved 6 March 2019.
  33. 1 2 "Recommended Uniform Screening Panel". U.S. Health Resources & Services Administration. Retrieved 2019-03-01.
  34. ↑ "Directors of Speech and Hearing Programs in State Health and Welfare Agencies" . Retrieved 2019-03-01.
  35. ↑ "Information About EHDI State Programs". U.S. Centers for Disease Control and Prevention. 2017-11-14. Retrieved 2019-03-05.
  36. ↑ Centers for Disease Control Prevention (CDC) (March 2010). "Identifying infants with hearing loss – United States, 1999–2007". Morbidity and Mortality Weekly Report. 59 (8): 220–3. PMID   20203554 – via U.S. Centers for Disease Control Prevention.
  37. 1 2 Gaffney M, Eichwald J, Gaffney C, Alam S (September 2014). "Early hearing detection and intervention among infants--hearing screening and follow-up survey, United States, 2005–2006 and 2009–2010". MMWR Supplements. 63 (2): 20–6. PMID   25208254.
  38. ↑ "Summary of 2016 National CDC EHDI Data" (PDF). U.S. Centers for Disease Control and Prevention. May 2018.
  39. ↑ American Academy Of Pediatrics, Joint Committee on Infant Hearing (October 2007). "Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs". Pediatrics. American Academy Of Pediatrics Joint Committee on Infant Hearing. 120 (4): 898–921. doi:10.1542/peds.2007-2333. PMID   17908777. S2CID   79426871.
  40. ↑ Alam S, Gaffney M, Eichwald J (2014). "Improved newborn hearing screening follow-up results in more infants identified". Journal of Public Health Management and Practice. 20 (2): 220–3. doi:10.1097/PHH.0b013e31829d7b57. PMC   4470168 . PMID   23803975.
  41. 1 2 Downs MP, Sterritt GM (1964). "Identification audiometry for neonates: a preliminary report". Journal of Auditory Research.
  42. ↑ Houston KT, Behl DD, White KR, Forsman I (August 2010). "Federal privacy regulations and the provision of Early Hearing Detection and Intervention programs". Pediatrics. 126 (Suppl 1): S28–33. doi:10.1542/peds.2010-0354G. PMID   20679317. S2CID   24742556.
  43. ↑ Russ SA, Dougherty D, Jagadish P (August 2010). "Accelerating evidence into practice for the benefit of children with early hearing loss". Pediatrics. 126 (Suppl 1): S7–18. doi:10.1542/peds.2010-0354E. PMID   20679322. S2CID   20355285.
  44. ↑ Russ SA, Hanna D, DesGeorges J, Forsman I (August 2010). "Improving follow-up to newborn hearing screening: a learning-collaborative experience". Pediatrics. 126 (Suppl 1): S59–69. doi:10.1542/peds.2010-0354K. PMID   20679321. S2CID   21281636.
  45. ↑ Shulman S, Besculides M, Saltzman A, Ireys H, White KR, Forsman I (August 2010). "Evaluation of the universal newborn hearing screening and intervention program". Pediatrics. 126 (Suppl 1): S19–27. doi:10.1542/peds.2010-0354F. PMID   20679316. S2CID   9448008.
  46. ↑ Wedenberg E (1956). "Auditory tests on newborn infants". Acta Oto-Laryngologica. 46 (5): 446–61. doi:10.3109/00016485609120155. PMID   13361864.
  47. ↑ "Joint Committee on Infant Hearing" (PDF). Retrieved 6 March 2019.
  48. ↑ Mahoney TM, Eichwald JG (May 1987). "The ups and "downs" of high-risk hearing screening: The Utah statewide program". Seminars in Hearing. 8 (2): 155–163. doi:10.1055/s-0028-1091366.
  49. ↑ "Early identification of hearing impairment in infants and young children". NIH Consensus Statement. 11 (1): 1–24. 1993. PMID   8401641.
  50. ↑ Northern JL, Downs MP (2002). "Chapter 1: Hearing and Hearing Loss in Children". Hearing in children. Lippincott Williams & Wilkins. p. 4.
  51. ↑ Walsh, James T. (1991-05-06). "Actions – H.R.2089 – 102nd Congress (1991–1992): Hearing Loss Testing Act of 1991". www.congress.gov. Retrieved 2019-03-01.
  52. ↑ Maxon AB, White KR, Vohr BR, Behrens TR (April 1993). "Using transient evoked otoacoustic emissions for neonatal hearing screening". British Journal of Audiology. 27 (2): 149–53. doi:10.3109/03005369309077906. PMID   8220282.
  53. ↑ Vohr BR, Carty LM, Moore PE, Letourneau K (September 1998). "The Rhode Island Hearing Assessment Program: experience with statewide hearing screening (1993–1996)". The Journal of Pediatrics. 133 (3): 353–7. doi:10.1016/S0022-3476(98)70268-9. PMID   9738715.
  54. ↑ Nelson HD, Bougatsos C, Nygren P (Jul 2008). "Universal newborn hearing screening: systematic review to update the 2001 US Preventive Services Task Force Recommendation". Pediatrics. 122 (1): e266–e276. doi:10.1542/peds.2007-1422. PMID   18595973. S2CID   40563482.
  55. ↑ "Information About EHDI State Programs". Centers for Disease Control and Prevention. 2017-11-14. Retrieved 2019-03-01.
  56. ↑ "Early Hearing Detection & Intervention". American Academy of Otolaryngology–Head and Neck Surgery. 2016-07-26. Retrieved 2019-03-01.
  57. ↑ White KR, Forsman I, Eichwald J, Munoz K (April 2010). "The evolution of early hearing detection and intervention programs in the United States". Seminars in Perinatology. 34 (2): 170–9. doi:10.1053/j.semperi.2009.12.009. PMID   20207267.
  58. ↑ "Profiles". IHE International. Retrieved 2019-03-01.
  59. ↑ "Newborn Screening Coding and Terminology Guide". U.S. National Library of Medicine. Retrieved 2019-03-01.
  60. ↑ "Electronic Clinical Quality Measure (eCQM) Standards Landscape" (PDF). HE Quality, Research and Public Health (QRPH) White Paper. IHE International, Inc. 6 February 2018.
  61. ↑ "Early Hearing Detection & Intervention Pediatric Audiology Links to Services (EHDI-PALS)" . Retrieved 2019-03-01.
  62. ↑ "HL7 Version 2.6 Implementation Guide: Early Hearing Detection and Intervention (EHDI) Results Release 1". HL7 International. Retrieved 2019-03-01.
  63. ↑ Katrin Neumann, Harald A. Euler, Shelley Chadha, Karl R. White (2020). "A Survey on the Global Status of Newborn and Infant Hearing Screening". The Journal of Early Hearing Detection and Intervention. 2 (2): 63–84. doi:10.26077/a221-cc28. S2CID   229246375 . Retrieved 2020-02-03.{{cite journal}}: CS1 maint: multiple names: authors list (link)

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.